Comparison of Different Hypotheses Regarding the Spread of Alzheimer's Disease Using Markov Random Fields and Multimodal Imaging.

Alzheimer's disease (AD) is characterized by a cascade of pathological processes that can be assessed in vivo using different neuroimaging methods. Recent research suggests a systematic sequence of pathogenic events on a global biomarker level, but little is known about the associations and dependencies of distinct lesion patterns on a regional level. Markov random fields are a probabilistic graphical modeling approach that represent the interaction between individual random variables by an undirected graph. We propose the novel application of this approach to study the interregional associations and dependencies between multimodal imaging markers of AD pathology and to compare different hypotheses regarding the spread of the disease. We retrieved multimodal imaging data from 577 subjects enrolled in the Alzheimer's Disease Neuroimaging Initiative. Mean amyloid load (AV45-PET), glucose metabolism (FDG-PET), and gray matter volume (MRI) were calculated for the six principle nodes of the default mode network- a functional network of brain regions that appears to be preferentially targeted by AD. Multimodal Markov random field models were developed for three different hypotheses regarding the spread of the disease: the "intraregional evolution model", the "trans-neuronal spread" hypothesis, and the "wear-and-tear" hypothesis. The model likelihood to reflect the given data was evaluated using tenfold cross-validation with 1,000 repetitions. The most likely graph structure contained the posterior cingulate cortex as main hub region with edges to various other regions, in accordance with the "wear-and-tear" hypothesis of disease vulnerability. Probabilistic graphical models facilitate the analysis of interactions between several variables in a network model and therefore afford great potential to complement traditional multiple regression analyses in multimodal neuroimaging research.

[1]  Bedda L. Rosario,et al.  Basal Cerebral Metabolism May Modulate the Cognitive Effects of Aβ in Mild Cognitive Impairment: An Example of Brain Reserve , 2009, The Journal of Neuroscience.

[2]  C. Jack,et al.  Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease , 1997, Neurology.

[3]  G. Chételat,et al.  Region-Specific Hierarchy between Atrophy, Hypometabolism, and β-Amyloid (Aβ) Load in Alzheimer's Disease Dementia , 2012, The Journal of Neuroscience.

[4]  M. Ewers,et al.  Distinct pattern of hypometabolism and atrophy in preclinical and predementia Alzheimer's disease , 2014, Neurobiology of Aging.

[5]  D. Drachman The amyloid hypothesis, time to move on: Amyloid is the downstream result, not cause, of Alzheimer's disease , 2014, Alzheimer's & Dementia.

[6]  M. Weiner,et al.  Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia , 2011, Trends in Neurosciences.

[7]  H. Rusinek,et al.  Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer’s disease , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[8]  Paul M. Thompson,et al.  Staging Alzheimer's disease progression with multimodality neuroimaging , 2011, Progress in Neurobiology.

[9]  Alan C. Evans,et al.  Epidemic Spreading Model to Characterize Misfolded Proteins Propagation in Aging and Associated Neurodegenerative Disorders , 2014, PLoS Comput. Biol..

[10]  Efstathios D. Gennatas,et al.  Predicting Regional Neurodegeneration from the Healthy Brain Functional Connectome , 2012, Neuron.

[11]  Damaris Zurell,et al.  Collinearity: a review of methods to deal with it and a simulation study evaluating their performance , 2013 .

[12]  J. Morris,et al.  The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[13]  Kristopher J Preacher,et al.  On the practice of dichotomization of quantitative variables. , 2002, Psychological methods.

[14]  Maurizio Corbetta,et al.  The human brain is intrinsically organized into dynamic, anticorrelated functional networks. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[15]  C. Jack,et al.  Comparison of 18F-FDG and PiB PET in Cognitive Impairment , 2009, Journal of Nuclear Medicine.

[16]  M. Greicius,et al.  Decoding subject-driven cognitive states with whole-brain connectivity patterns. , 2012, Cerebral cortex.

[17]  Stefan J. Teipel,et al.  The relative importance of imaging markers for the prediction of Alzheimer's disease dementia in mild cognitive impairment — Beyond classical regression , 2015, NeuroImage: Clinical.

[18]  Alan C. Evans,et al.  Spatial patterns of cortical thinning in mild cognitive impairment and Alzheimer's disease. , 2006, Brain : a journal of neurology.

[19]  Xiaoming Yuan,et al.  The flare package for high dimensional linear regression and precision matrix estimation in R , 2020, J. Mach. Learn. Res..

[20]  J. Hardy,et al.  Amyloid deposition as the central event in the aetiology of Alzheimer's disease. , 1991, Trends in pharmacological sciences.

[21]  Olaf Sporns,et al.  Structural Network Topology Revealed by White Matter Tractography in Cannabis Users: A Graph Theoretical Analysis , 2011, Brain Connect..

[22]  C. Jack,et al.  An operational approach to National Institute on Aging–Alzheimer's Association criteria for preclinical Alzheimer disease , 2012, Annals of neurology.

[23]  M. Weiner,et al.  A Network Diffusion Model of Disease Progression in Dementia , 2012, Neuron.

[24]  N. Foster,et al.  Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease , 1997, Annals of neurology.

[25]  Kewei Chen,et al.  Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease. , 2011, Archives of neurology.

[26]  A. Drzezga,et al.  Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[27]  Peter Stoeter,et al.  Diagnostic utility of hippocampal size and mean diffusivity in amnestic MCI , 2007, Neurobiology of Aging.

[28]  Te-Chun Hsieh,et al.  Sex‐ and Age‐Related Differences in Brain FDG Metabolism of Healthy Adults: An SPM Analysis , 2012, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[29]  Keith A. Johnson,et al.  In Vivo Tau, Amyloid, and Gray Matter Profiles in the Aging Brain , 2016, The Journal of Neuroscience.

[30]  G L Shulman,et al.  INAUGURAL ARTICLE by a Recently Elected Academy Member:A default mode of brain function , 2001 .

[31]  Keith A. Johnson,et al.  Amyloid-β deposition in mild cognitive impairment is associated with increased hippocampal activity, atrophy and clinical progression. , 2015, Brain : a journal of neurology.

[32]  A. Bokde,et al.  Assessing neuronal networks: Understanding Alzheimer's disease , 2009, Progress in Neurobiology.

[33]  C. Rowe,et al.  Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism , 2008, The Lancet Neurology.

[34]  J. Gunter,et al.  Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease , 2012, Neurology.

[35]  K. Wienhard,et al.  Normal and pathological aging – findings of positron-emission-tomography , 1998, Journal of Neural Transmission.

[36]  Stefan Teipel,et al.  Cholinergic basal forebrain atrophy predicts amyloid burden in Alzheimer's disease , 2014, Neurobiology of Aging.

[37]  C. Jack,et al.  Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers , 2013, The Lancet Neurology.

[38]  Li Shen,et al.  Baseline MRI Predictors of Conversion from MCI to Probable AD in the ADNI Cohort , 2009, Current Alzheimer research.

[39]  Michael Weiner,et al.  Network Diffusion Model of Progression Predicts Longitudinal Patterns of Atrophy and Metabolism in Alzheimer's Disease. , 2015, Cell reports.

[40]  S. Teipel,et al.  Spatial patterns of atrophy, hypometabolism, and amyloid deposition in Alzheimer's disease correspond to dissociable functional brain networks , 2016, Human brain mapping.

[41]  Sébastien Ourselin,et al.  Head size, age and gender adjustment in MRI studies: a necessary nuisance? , 2010, NeuroImage.

[42]  M. Greicius,et al.  Default-mode network activity distinguishes Alzheimer's disease from healthy aging: Evidence from functional MRI , 2004, Proc. Natl. Acad. Sci. USA.

[43]  Bernard Ng,et al.  Regional brain hypometabolism is unrelated to regional amyloid plaque burden. , 2015, Brain : a journal of neurology.

[44]  Keith A. Johnson,et al.  Cortical Hubs Revealed by Intrinsic Functional Connectivity: Mapping, Assessment of Stability, and Relation to Alzheimer's Disease , 2009, The Journal of Neuroscience.

[45]  Charles DeCarli,et al.  Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation. , 2015, Brain : a journal of neurology.

[46]  N. Schuff,et al.  Multimodal imaging in Alzheimer's disease: validity and usefulness for early detection , 2015, The Lancet Neurology.

[47]  Benjamin J. Shannon,et al.  Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory , 2005, The Journal of Neuroscience.

[48]  M. Bobinski,et al.  The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer's disease , 1999, Neuroscience.

[49]  B. Miller,et al.  Neurodegenerative Diseases Target Large-Scale Human Brain Networks , 2009, Neuron.

[50]  Peng Yu,et al.  Relationship of Hippocampal Volume to Amyloid Burden across Diagnostic Stages of Alzheimer's Disease , 2015, Dementia and Geriatric Cognitive Disorders.

[51]  Jian Wang,et al.  Alterations of whole-brain cortical area and thickness in mild cognitive impairment and Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.

[52]  Lea T Grinberg,et al.  Cognitive Correlates of Basal Forebrain Atrophy and Associated Cortical Hypometabolism in Mild Cognitive Impairment. , 2016, Cerebral cortex.

[53]  Gereon R. Fink,et al.  Impact of tau and amyloid burden on glucose metabolism in Alzheimer's disease , 2016, Annals of clinical and translational neurology.

[54]  Nikos Komodakis,et al.  Markov Random Field modeling, inference & learning in computer vision & image understanding: A survey , 2013, Comput. Vis. Image Underst..

[55]  H. Heinsen,et al.  Longitudinal measures of cholinergic forebrain atrophy in the transition from healthy aging to Alzheimer's disease , 2013, Neurobiology of Aging.

[56]  James Robert Brašić,et al.  In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand 18F-AV-45 (Flobetapir F 18) , 2010, Journal of Nuclear Medicine.

[57]  S. Soriano,et al.  On the origin of Alzheimer's disease. Trials and tribulations of the amyloid hypothesis , 2014, Ageing Research Reviews.

[58]  Alex Becker,et al.  In vivo characterization of the early states of the amyloid-beta network. , 2013, Brain : a journal of neurology.

[59]  M. Reivich,et al.  Labeled 2-deoxy-D-glucose analogs. 18F-labeled 2-deoxy-2-fluoro-D-glucose, 2-deoxy-2-fluoro-D-mannose and 14C-2-deoxy-2-fluoro-D-glucose , 1978 .

[60]  R. Coleman,et al.  Use of florbetapir-PET for imaging beta-amyloid pathology. , 2011, JAMA.

[61]  R H Huesman,et al.  Regional Cerebral Metabolic Alterations in Dementia of the Alzheimer Type: Positron Emission Tomography with [1818] Fluorodeoxyglucose , 1983, Journal of computer assisted tomography.

[62]  Francis Eustache,et al.  Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer's disease , 2013, NeuroImage: Clinical.

[63]  Michael W. Weiner,et al.  Mapping 3-year changes in gray matter and metabolism in Aβ-positive nondemented subjects , 2015, Neurobiology of Aging.

[64]  Maximilian Reiser,et al.  White matter microstructure underlying default mode network connectivity in the human brain , 2010, NeuroImage.

[65]  Stefan Teipel,et al.  Does posterior cingulate hypometabolism result from disconnection or local pathology across preclinical and clinical stages of Alzheimer’s disease? , 2016, European Journal of Nuclear Medicine and Molecular Imaging.

[66]  Gemma C. Garriga,et al.  Permutation Tests for Studying Classifier Performance , 2009, 2009 Ninth IEEE International Conference on Data Mining.

[67]  Maximilian Reiser,et al.  Multivariate deformation-based analysis of brain atrophy to predict Alzheimer's disease in mild cognitive impairment , 2007, NeuroImage.

[68]  Denise C. Park,et al.  Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[69]  Harald Hampel,et al.  Diagnostic power of default mode network resting state fMRI in the detection of Alzheimer's disease , 2012, Neurobiology of Aging.

[70]  Yen-Hsiang Chang,et al.  Amyloid Burden in the Hippocampus and Default Mode Network , 2015, Medicine.

[71]  Zhiqiang Zhang,et al.  Gender Differences of Brain Glucose Metabolic Networks Revealed by FDG-PET: Evidence from a Large Cohort of 400 Young Adults , 2013, PloS one.

[72]  S. Teipel,et al.  Multimodal analysis of functional and structural disconnection in Alzheimer's disease using multiple kernel SVM , 2015, Human brain mapping.

[73]  Marine Fouquet,et al.  Sequential relationships between grey matter and white matter atrophy and brain metabolic abnormalities in early Alzheimer's disease. , 2010, Brain : a journal of neurology.

[74]  M N Rossor,et al.  Intracranial volume and Alzheimer disease: evidence against the cerebral reserve hypothesis. , 2000, Archives of neurology.

[75]  Paolo Maria Rossini,et al.  Brain excitability and connectivity of neuronal assemblies in Alzheimer's disease: From animal models to human findings , 2012, Progress in Neurobiology.

[76]  Maximilian Reiser,et al.  Multivariate network analysis of fiber tract integrity in Alzheimer’s disease , 2007, NeuroImage.

[77]  C. Stam Modern network science of neurological disorders , 2014, Nature Reviews Neuroscience.

[78]  W. Klunk,et al.  Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B , 2004, Annals of neurology.

[79]  John Ashburner,et al.  A fast diffeomorphic image registration algorithm , 2007, NeuroImage.

[80]  Martin Hallbeck,et al.  Neuron-to-Neuron Transmission of Neurodegenerative Pathology , 2013, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[81]  Trevor Hastie,et al.  Learning the Structure of Mixed Graphical Models , 2015, Journal of computational and graphical statistics : a joint publication of American Statistical Association, Institute of Mathematical Statistics, Interface Foundation of North America.

[82]  M N Rossor,et al.  Patterns of temporal lobe atrophy in semantic dementia and Alzheimer's disease , 2001, Annals of neurology.

[83]  Sébastien Ourselin,et al.  Multiple Orderings of Events in Disease Progression , 2015, IPMI.

[84]  W. Jagust,et al.  Apolipoprotein E, Not Fibrillar β-Amyloid, Reduces Cerebral Glucose Metabolism in Normal Aging , 2012, The Journal of Neuroscience.

[85]  Stefan J. Teipel,et al.  Basal forebrain atrophy and cortical amyloid deposition in nondemented elderly subjects , 2014, Alzheimer's & Dementia.